Pharmaceutical giants Novo Nordisk and Eli Lilly are in fierce competition to dominate the weight management drug market as their respective obesity medications have taken center stage this summer.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.